Fundraising Fox
Avenacy
Schaumburg, US · Founded 2023 · Delaware corporation
Find your way into Avenacy
Sign up to see every warm intro you have to Avenacy
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Avenacy team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Avenacy develops and supplies sterile injectable medications for pharmacists and patients, with packaging and labeling designed to reduce administration errors and dosing mistakes. It operates in the pharmaceutical industry with a focus on injectable drug products.
Founders & leadership
Avenacy was founded in 2023 by Jeffrey Yordon.
JY
Jeffrey YordonFounder
JM
Joe MaseChief Operating & Commercial OfficerJoe Mase is an executive with experience in the pharmaceutical injectable sector, including roles building and scaling businesses focused on generic injectables, compounding, and IV products. He previously led commercial operations at Athenex and helped grow Sagent's injectable business to over $400M in annual revenue.
KP
Kam PhulwaniExecutive
Board
PS
Patrick Soon-ShiongBoard director
DR
Douglas Reed MaughanBoard director
Reported raises · per SEC filings
Form D private placements$26M disclosed across 1 round · 2024
▶$26MraisedNov 2024 · 2 investors · PharmaceuticalsRule 506(b)
▶$26MraisedNov 2024 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Patrick Soon-ShiongDirector
- Jeffrey YordonExecutive Officer, Director
- Joe MaseExecutive Officer
- Douglas Reed MaughanDirector
- Kam PhulwaniExecutive Officer, Director
- Offering amount
- $34M
- Amount sold
- $26M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Avenacy do?
- Avenacy develops and supplies sterile injectable medications for pharmacists and patients, with packaging and labeling designed to reduce administration errors and dosing mistakes. It operates in the pharmaceutical industry with a focus on injectable drug products.
- Who founded Avenacy?
- Avenacy was founded by Jeffrey Yordon in 2023.
- How much funding has Avenacy raised?
- Avenacy has disclosed $26M raised across 1 round.
- Where is Avenacy headquartered?
- Avenacy is headquartered in Schaumburg, US.